Jeonbuk National University Hospital
Jeonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mature T-cell and NK-cell non-Hodgkin lymphoma, neoplasm | Recruiting | Phase 3 | 2026-07-22 | NCT06072131 | |
| Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke) | Acute Ischemic Stroke, Digestive System Diseases, Gastrointestinal Hemorrhage, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, digestive system disorder, ischemic stroke, nervous system disorder, stroke disorder, transient ischemic attack, vascular disorder | Recruiting | Phase 3 | 2026-07-08 | NCT07687706 | |
| A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants | Digestive System Diseases, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, colitis, colonic disorder, connective tissue disorder, digestive system disorder, gastroenteritis, immune system disorder, inflammatory bowel disease, intestinal disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis, ulcerative colitis | Recruiting | Not stated | 2026-07-06 | NCT06246123 | |
| A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Active, not recruiting | Phase 3 | 2026-06-25 | NCT05144854 | |
| Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-04-17 | NCT04725994 | |
| Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, herpes zoster, viral infectious disease | Not yet recruiting | Phase 2 | 2026-03-19 | NCT07481604 | |
| A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Active, not recruiting | Phase 2 | 2026-03-13 | NCT06256328 |